Disease Overview：Uterine leiomyoma（ULM）
Uterine fibroids—benign smooth muscle tumors of the myometrium—are the most common gynecologic neoplasms in women of reproductive age. Prevalence estimates range from 20% to 80%, varying by ethnicity, age, and diagnostic method. While many cases remain asymptomatic, clinical manifestations may include menorrhagia, pelvic pressure or pain, urinary frequency, dyspareunia, and infertility—particularly when submucosal or large intramural fibroids distort the endometrial cavity or impair tubal patency. Diagnosis relies on transvaginal ultrasound, MRI for complex cases or pre-procedural mapping, and occasionally hysteroscopy. Management is individualized: watchful waiting for asymptomatic patients; medical therapy (e.g., GnRH agonists, selective progesterone receptor modulators) for symptom control or preoperative shrinkage; and definitive interventions including hysteroscopic resection, laparoscopic or robotic myomectomy, uterine artery embolization, or hysterectomy—depending on fibroid size, number, location, and patient fertility goals.
China offers distinct advantages for international patients seeking fibroid management. Leading tertiary hospitals—many accredited by JCI or ISO—employ reproductive endocrinologists and minimally invasive gynecologic surgeons with extensive experience in fertility-sparing techniques, including advanced hysteroscopic resection (e.g., resectoscopes with real-time ultrasound guidance) and robotic-assisted myomectomy. High-field MRI and 3D-ultrasound platforms enable precise preoperative characterization, while outcomes data from centers like Peking University First Hospital and Shanghai Obstetrics and Gynecology Hospital demonstrate >90% symptom resolution and preserved fertility rates comparable to Western benchmarks. Crucially, costs for comprehensive care—including diagnostics, surgery, anesthesia, and postoperative follow-up—are typically 40–60% lower than in the US or EU, without compromising safety or efficacy. As a dedicated medical tourism agency, we facilitate seamless access to these resources: vetting top-tier hospitals, coordinating appointments with English-speaking specialists, providing itemized, transparent pricing upfront, arranging visas and local logistics, and offering continuous bilingual support before, during, and after treatment.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Uterine Fibroids (Gynecology/Reproductive Medicine)
Non-Surgical & Medical Management
*Indicated for asymptomatic, small (<5 cm), or premenopausal patients seeking fertility preservation or symptom control.*
- •Hormonal Therapy (GnRH agonists, oral contraceptives, progestins)
- *Cost (3-month course):* - GnRH agonist (e.g., leuprolide acetate injection): $280–$420 - Combined oral contraceptive pills (generic): $12–$35 - Oral progestin (e.g., norethisterone): $8–$22 - *Required baseline exams:* Pelvic ultrasound ($45), CBC ($12), liver function test ($18), serum estradiol ($20) → $95 total
- •Tranexamic Acid (for heavy menstrual bleeding)
- *Cost (1-month supply):* $6–$15 - *Lab monitoring (annually):* D-dimer + coagulation panel → $38
Surgical & Interventional Procedures
*Indicated for symptomatic fibroids ≥5 cm, rapid growth, infertility, or compressive symptoms.*
- •Laparoscopic Myomectomy
- *Procedure cost:* $2,100–$3,400 - *Pre-op workup:* ECG ($10), chest X-ray ($15), pelvic MRI ($180), anesthesiology consult ($40) → $245 total
- •Hysteroscopic Myomectomy (for submucosal fibroids ≤4 cm)
- *Procedure cost:* $1,750–$2,600 - *Pre-op workup:* Hysteroscopy prep + saline infusion sonography ($110), endometrial biopsy ($35) → $145 total
- •Uterine Artery Embolization (UAE)
- *Procedure cost:* $2,900–$4,100 - *Pre-op workup:* Pelvic angiogram ($220), renal function panel ($25), contrast allergy screening ($18) → $263 total
Special/Complex Scenarios
- •Large或多fibroid burden (>10 cm or >5 fibroids): Open abdominal myomectomy — $3,600–$5,200, plus extended ICU monitoring ($120/day × 2 days).
- •Fibroid-related infertility with IVF planning: Combined hysteroscopic + laparoscopic myomectomy — $4,300–$6,000, including embryo transfer coordination fee ($280).
- •Postmenopausal rapid growth (suspicious malignancy): Total hysterectomy + frozen section pathology — $3,800–$5,500, with oncologic pathology add-on ($190).
Quick Selection Guide
- •<35 years, fertility desired, <6 cm: Laparoscopic myomectomy ($2,100–$3,400) — optimal balance of preservation and efficacy.
- •35–45 years, moderate symptoms, no fertility plans: UAE ($2,900–$4,100) — minimally invasive, faster recovery.
- •>45 years, severe menorrhagia, comorbidities (hypertension/diabetes): Hormonal therapy + tranexamic acid ($290–$455/year) — lowest risk, cost-effective first-line.
- •Budget-constrained (<$500), asymptomatic/small fibroids: Surveillance + oral progestin ($8–$22/month) — avoids procedural costs while controlling bleeding.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Uterine leiomyoma Medical Vacation Packages
Curated transparent all-inclusive packages combining Uterine leiomyoma treatment with China top medical destinations:
